Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2016)
Biomarin Pharmaceutical (BMRN) recorded quarterly Receivables - Other of $8.4 million in Q3 2016, down 92.79% on a QoQ basis from $116.5 million in Q4 2013.
Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2016) Analysis & Trends
Biomarin Pharmaceutical has disclosed Receivables - Other across 5 years of filings, most recently posting $8.4 million for Q3 2016.
- Quarterly Receivables - Other changed N/A year-over-year to $8.4 million in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $8.4 million (changed N/A YoY) and the FY2013 annual result came in at $116.5 million, changed N/A from the prior year.
- Receivables - Other eased to $8.4 million in Q3 2016, from $116.5 million in the prior quarter.
- Over five years, Receivables - Other peaked at $116.5 million in Q4 2013 and troughed at $6.8 million in Q1 2012.
- A 3-year average of $30.1 million and a median of $9.0 million in 2012 frame the typical range for Receivables - Other.
- Biggest YoY gain for Receivables - Other was 111.9% in 2012; the steepest drop was 23.81% in 2012.
- Tracing BMRN's Receivables - Other over 3 years: stood at $9.0 million in 2012, then jumped by 1191.86% to $116.5 million in 2013, then plunged by 92.79% to $8.4 million in 2016.
- Business Quant data shows BMRN's Receivables - Other at $8.4 million in Q3 2016, $116.5 million in Q4 2013, and $9.0 million in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Biomarin Pharmaceutical | 10.52 Bn | 8.29 Bn | 571.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 8.40 Mn |
| Sep 30, 2016 | 8.40 Mn |
| Dec 31, 2013 | 116.50 Mn |
| Dec 31, 2013 | 116.50 Mn |
| Sep 30, 2012 | 9.02 Mn |
| Sep 30, 2012 | 9.02 Mn |
| Jun 30, 2012 | 9.78 Mn |
| Jun 30, 2012 | 9.78 Mn |
| Mar 31, 2012 | 6.83 Mn |
| Mar 31, 2012 | 6.83 Mn |
| Dec 31, 2011 | 6.09 Mn |
| Dec 31, 2011 | 6.09 Mn |
| Sep 30, 2011 | 7.28 Mn |
| Sep 30, 2011 | 7.28 Mn |
| Jun 30, 2011 | 4.61 Mn |
| Jun 30, 2011 | 4.61 Mn |
| Dec 31, 2010 | 7.31 Mn |
| Dec 31, 2010 | 7.31 Mn |